Safety Study of FluMist With and Without Ampligen

Clinical trial NCT01591473 · TERMINATED

Trial details

NCT number: NCT01591473
Sponsor: AIM ImmunoTech Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2012-04-01
Primary completion: 2014-09-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.